Clinical Trials Browser

Phase 3 × Completed × Tenofovir × Clear all

NCT02650271 2024-01-23

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular